Boehringer Ingelheim: Takeover in immunoon...Boehringer Ingelheim has acquired Texan biotech Abexxa Biologics Inc., further expanding its cancer immunotherapy pipeline. more ➔
AstraZeneca puts €307m in Irish Alexion...Following the $39bn Alexion buy-out completed in July, AstraZeneca plc announced it will invest €307m in the company’s producion site near Dublin. more ➔
Bayer: Peptide deal with GubraBayer AG has joined forces with young Danish biotech Gubra ApS in a research collaboration and license agreement for the development of peptide therapeutics to treat cardiorenal diseases. more ➔
Foundation launches Harvard research hubThe Novo Nordisk Foundation is investing US$47.5m into a research collaboration with the Broad Institute of MIT and Harvard, intending to dive into the disease mechanisms of diabetes and obesity. more ➔
Touchlight extends funding round to boost...UK-based DNA synthesis specialist Touchlight Ltd has extended a funding round to a current aggregate total of US $125m. more ➔
Meatable teams up with Royal DSMRoyal DSM is backing Meatable, the cultivated meat start-up, in order to develop growth media for cultivated meat. more ➔
US$21m for microbiome therapiesEnteroBiotix closes an oversubscribed Series A financing with US$21.5m. The biopharma company will use the proceeds to advance its microbiome drug pipeline. more ➔
Swiss Biotech Day shows great biopharma am...The Swiss biopharmaceutical industry is on the verge of record growth: This was demonstrated at the live Swiss Biotech Day in Basel. more ➔
Owlstone: US$59m for breath biopsy develop...Owlstone Medical has raised US$59m in a Series D financing round. The proceeds will be used to continue development of the companys breath biopsy tests. more ➔
EU ends litigation with AstraZenecaThe EU Commission and AstraZeneca have settled their ongoing legal dispute over the supply of COVID-19 vaccine doses. They agreed to a new delivery schedule. more ➔
